| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| bay 60-6583 | adenosine a1 receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronary Arteriosclerosis[MeSHID:D003324] Myocardial Ischemia[MeSHID:D017202] |
NA | preclinical | agonist |
| bay 60-6583 | adenosine a2b receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronary Arteriosclerosis[MeSHID:D003324] Myocardial Ischemia[MeSHID:D017202] |
NA | preclinical | agonist |
| bay 60-6583 | adenosine a3 receptor | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronary Arteriosclerosis[MeSHID:D003324] Myocardial Ischemia[MeSHID:D017202] |
NA | preclinical | agonist |
| click here to return to the previous page | ||||||||